Pfizer Inc. (PFE) Stock
PFE Key Statistics
About Pfizer Inc.
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
CEO: Albert Bourla. Company website
PFE — Frequently Asked Questions
What is the PFE stock price today?
Pfizer Inc. (PFE) trades at $27.60, down 0.14% on the day, as of Sep 20, 2026 13:08 UTC.
What is Pfizer Inc.'s market cap?
Pfizer Inc. has a market capitalisation of $157.30B, calculated from the live PFE share price and shares outstanding.
What is the P/E ratio of PFE?
PFE trades at a trailing P/E of 36.32, from earnings per share of $0.76 over the last twelve months.
How much revenue does Pfizer Inc. make?
Pfizer Inc. generated revenue of $63.70B over the trailing twelve months, which puts the stock at 2.47 times sales.
Does PFE pay a dividend?
Yes. Pfizer Inc. pays a dividend yielding 6.79% on the current share price.
What is the 52-week range for PFE?
PFE has traded between $23.58 and $29.21 over the past 52 weeks, and the last price is 5.5% below that high.
Is Pfizer Inc. profitable?
Yes. Pfizer Inc. keeps 6.81% of revenue as net income over the trailing twelve months.
What is the analyst price target for PFE?
Wall Street analysts rate PFE Hold, with an average price target of $28.20, 2.2% above the current price.
What sector is Pfizer Inc. in?
Pfizer Inc. is classified under the Healthcare sector and the Drug Manufacturers - General industry, and is domiciled in US.
Who is the CEO of Pfizer Inc.?
Albert Bourla is the chief executive of Pfizer Inc., which employs 75,000 people.
Where can I track PFE in real time?
QFI Terminal shows PFE with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See PFE live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open PFE in Terminal See plans